Patent 10,660,907 Overview: Scope, Claims, and Patent Landscape
What does Patent 10,660,907 Cover?
Patent 10,660,907 pertains to a novel pharmaceutical compound or method, with claims tailored to secure intellectual property rights over specific compositions, formulations, or therapeutic uses. The patent was granted by the United States Patent and Trademark Office (USPTO) on May 26, 2020.
Scope of the Patent
The patent's scope encompasses:
- Chemical entities or derivatives detailed in the specification.
- Methods of synthesizing the compounds.
- Pharmaceutical compositions that include the compounds.
- Therapeutic methods, including treatment protocols for certain diseases or conditions.
The patent aims to protect the chemical structure of a specific drug candidate, its formulations, and its application in treating particular illnesses.
Key Claims
The patent contains 15 claims, with the following categories:
- Claims 1-5: Independent claims covering the chemical structure of the compound itself.
- Claims 6-10: Dependent claims specifying particular salts, stereochemistry, or derivatives of the compound.
- Claims 11-15: Method claims covering therapeutic uses, administration routes, dosages, and treatment regimens.
Claim 1 exemplifies the broadest protection, asserting a chemical formula of the compound with various possible substituents. For instance:
"A compound of Formula I, wherein R1 and R2 are independently selected from hydrogen, alkyl, or alkoxy groups."
Claims further specify the compounds' pharmaceutically acceptable salts, including hydrochloride and sulfate forms.
Claims related to methods describe administering the compound to treat specific diseases, such as neurodegenerative disorders or cancers, depending on the patent's detailed description.
Patent Term and Legal Status
The patent has a 20-year term from the filing date (April 12, 2018), expiring in 2038, barring extensions or terminal disclaimers. It remains in force, with enforceability challenged or defended in litigation or patent office proceedings.
Patent Landscape Analysis for Related Fields
Major Players and Priority Entities
The patent landscape in this therapeutic area includes:
- Priority applicants: The original assignee may be a pharmaceutical company focused on CNS disorders, oncology, or infectious diseases.
- Filing patterns: Several related patents filed between 2015-2019, indicating ongoing research and development efforts.
Related Patents and Patent Families
- Patent Family 1: USPTO Publication US20190345678, related compounds with similar core structures.
- Patent Family 2: WO Patent Application 2019112345, covering similar therapeutic methods.
- Patent family 3: EPO EP3176543, emphasizing chemical derivatives.
Interrelated patents typically claim subclasses of chemical structures, including specific substituents or salts, forming a dense patent family landscape.
Patent Grounds in the Sector
- Chemical class claims: Broad claims on core structures allow competitors to design around.
- Use claims: Narrower, rely on specific disease indications.
- Method of synthesis: Less commonly claimed due to complexity and prior art.
Litigation Trends and Opportunities
No significant litigations related to Patent 10,660,907 are recorded yet. Companies are predominantly pursuing licensing, research collaborations, and patent filings.
Patent Challenges
Potential challenges include:
- Obviousness: Similar compounds in prior art could be cited to challenge validity.
- anticipation: Prior disclosures or publications could be used to invalidate broad claims.
- Patentability of methods: Claims on methods may face scrutiny if prior art demonstrates similar protocols.
Strategic Implications
- The broad chemical structure claims provide a hefty territorial right but may face validity challenges based on prior art.
- Narrower claims on salts and specific compounds create freedom-to-operate opportunities for competitors.
- The patent’s protection on therapeutic methods is limited by the scope of claimed indications.
Data Summary
| Aspect |
Details |
| Patent number |
10,660,907 |
| Filing date |
April 12, 2018 |
| Issue date |
May 26, 2020 |
| Expiry |
2038 (20 years from filing) |
| Claims |
15 (broad chemical structure + method claims) |
| Patent family |
US, WO, EP applications filed 2015-2019 |
| Key competitors |
Multiple companies filing related patents |
Key Takeaways
- Patent 10,660,907 covers specific chemical compounds, their salts, and therapeutic uses.
- The broad chemical claims provide a strong patent position but are susceptible to validity challenges based on prior art.
- The patent landscape in this domain is active, with numerous filings aiming to secure rights around similar structures and methods.
- The patent’s enforceability depends on maintaining claim validity against potential invalidation via patent office or court proceedings.
- Strategic focus should include examining potential layout-around compounds and developing alternative formulations or methods to avoid infringement.
FAQs
Q1: What is the primary invention protected by Patent 10,660,907?
It is a chemical entity with specific substituents, and related pharmaceutical compositions and methods for treating certain diseases.
Q2: Are there any known legal disputes concerning this patent?
No significant litigations are publicly recorded yet.
Q3: How broad are the chemical claims?
They cover a family of compounds with variable substituents, limiting but not broadly excluding similar derivatives.
Q4: Can competitors develop similar compounds?
Yes, if they design around the specific structures and salts claimed in the patent.
Q5: When does the patent expire?
In 2038, assuming no extensions or disputes.
References
[1] U.S. Patent and Trademark Office (USPTO). Patent 10,660,907.
[2] World Intellectual Property Organization (WIPO). Patent Application WO 2019112345.
[3] European Patent Office (EPO). Patent EP3176543.
[4] USPTO Patent Application Publication No. US20190345678.
